Fig. S9.

Tumor-associated macrophages (TAMs) and dendritic cells (DCs) in CRCs treated with anti-VEGFR2 therapy. C57BL/6 WT mice bearing SL4 tumors (A and B) and BALB/c WT mice bearing syngeneic orthotopic CT26 tumors (C and D) were treated with either control rat IgG (C), AMD3100 (A), DC101 (D), or AMD3100 + DC101 (A+D). TAMs and DCs in the tumor were analyzed by flow cytometry on day 12. Data are represented as mean ± SEM, n = 7 per group. NS, nonsignificant. The graphs depict the absolute number of cells per milligram of tumor tissue.